a month ago
LLY
AnalystsAkash TewariAkash Tewari's Stock Forecasts
AnalystsAkash Tewari
Analyst Ranking
Top 31%
#1663 out of 5327 analysts
Average Return
+2.91%
Win Rate
39%22 out of 57
Risk vs Reward
Poor
Good
Akash Tewari's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Terns Pharmaceuticals IncTERN | +277.41% | $14.03 | $52.95 | 2025-11-03 - 2026-05-04 | Strong Buy |
Global Blood Therapeutics IncGBT | +139.48% | $27.81 | $66.60 | 2021-10-07 - 2022-08-08 | Strong Buy |
Apogee Therapeutics IncAPGE | +90.45% | $21.46 | $40.87 | 2023-08-08 - 2024-08-07 | Strong Buy |
Apogee Therapeutics IncAPGE | +90.45% | $21.46 | $40.87 | 2023-08-08 - 2024-08-07 | Strong Buy |
Cytokinetics IncCYTK | +64.33% | $22.82 | $37.50 | 2021-03-12 - 2022-03-11 | Buy |
Akash Tewari Analyst Color
Get additional color on Akash Tewari's coverage of popular stocks
2 years ago
IONS
2 years ago
LLY
2 years ago
LLY
2 years ago
APGE
2 years ago
APLS
3 years ago
PFE
3 years ago
LLY
3 years ago
LLY
3 years ago
LLY
3 years ago
PFE
4 years ago
ZYME
4 years ago
BMRN
5 years ago
BNTX
Akash Tewari's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ionis Pharmaceuticals IncIONS | 3 | Strong Buy | $90.00 | +69.97% | Maintains | 13 days ago |
Apogee Therapeutics IncAPGE | 5 | Hold | $135.00 | +0.63% | Downgrades | a month ago |
Eli Lilly & CoLLY | 7 | Strong Buy | $1,350.00 | +17.71% | Maintains | a month ago |
Spyre Therapeutics IncSYRE | 2 | Strong Buy | $85.00 | -12.67% | Maintains | 3 months ago |
Biontech SeBNTX | 4 | Strong Buy | $138.00 | +49.74% | Maintains | 4 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Strong Buy | $580.00 | +20.71% | Initiates Coverage On | 4 months ago |
Amgen IncAMGN | 1 | Hold | $350.00 | -3.89% | Initiates Coverage On | 4 months ago |
Gilead Sciences IncGILD | 1 | Strong Buy | $180.00 | +35.12% | Initiates Coverage On | 4 months ago |
Terns Pharmaceuticals IncTERN | 2 | Strong Buy | $35.00 | -33.90% | Maintains | 9 months ago |
Regeneron Pharmaceuticals IncREGN | 5 | Strong Buy | $831.00 | +23.63% | Maintains | a year ago |
Crescent Biopharma IncCBIO | 1 | Strong Buy | $26.00 | +72.76% | Initiates Coverage On | a year ago |
Arvinas IncARVN | 3 | Hold | $10.00 | N/A | Downgrades | a year ago |
Bristol Myers Squibb CoBMY | 4 | Strong Buy | $68.00 | N/A | Maintains | a year ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $95.00 | N/A | Initiates Coverage On | 2 years ago |
Relay Therapeutics IncRLAY | 3 | Strong Buy | $16.00 | N/A | Upgrades | 2 years ago |
Neurocrine Biosciences IncNBIX | 2 | Strong Buy | $189.00 | N/A | Maintains | 2 years ago |
Apellis Pharmaceuticals IncAPLS | 2 | Strong Buy | $80.00 | N/A | Maintains | 2 years ago |
Alkermes PLCALKS | 2 | Strong Buy | $50.00 | N/A | Maintains | 2 years ago |
Acelyrin IncSLRN | 2 | Strong Buy | $12.00 | N/A | Maintains | 3 years ago |
Pfizer IncPFE | 2 | Strong Buy | $39.00 | N/A | Upgrades | 3 years ago |
Enanta Pharmaceuticals IncENTA | 2 | Hold | $18.00 | N/A | Downgrades | 3 years ago |
Argenx SeARGX | 2 | Strong Buy | $513.00 | N/A | Maintains | 3 years ago |
Merck & Co IncMRK | 1 | Strong Buy | $125.00 | N/A | Initiates Coverage On | 3 years ago |
Zymeworks IncZYME | 1 | Strong Buy | $11.00 | N/A | Upgrades | 4 years ago |
Third Harmonic Bio IncTHRD | 2 | Hold | $3.60 | N/A | Downgrades | 4 years ago |
Acrivon Therapeutics IncACRV | 1 | Strong Buy | $17.00 | N/A | Initiates Coverage On | 4 years ago |
Eqrx IncEQRX | 2 | Hold | $3.20 | N/A | Downgrades | 4 years ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 4 years ago |
Cytokinetics IncCYTK | 2 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 5 years ago |
Madrigal Pharmaceuticals IncMDGL | 1 | Strong Buy | $151.00 | N/A | Initiates Coverage On | 5 years ago |
Exelixis IncEXEL | 2 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | $180.00 | N/A | Initiates Coverage On | 5 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Buy | $107.00 | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.